Immunogenicity Risk Assessment for Multi-specific Therapeutics

The objective of this manuscript is to provide the reader with a hypothetical case study to present an immunogenicity risk assessment for a multi-specific therapeutic as part of Investigational New Drug (IND) application. In order to provide context for the bioanalytical strategies used to support t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kroenke, Mark A., Milton, Mark N., Kumar, Seema, Bame, Eris, White, Joleen T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571146/
https://www.ncbi.nlm.nih.gov/pubmed/34741215
http://dx.doi.org/10.1208/s12248-021-00642-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571146/
https://www.ncbi.nlm.nih.gov/pubmed/34741215
http://dx.doi.org/10.1208/s12248-021-00642-5

Ejemplares similares